The mechanisms by which type I interferons (IFN) reduce the rate and severity of exacerbations in multiple sclerosis are unknown. We utilized a model of multiple sclerosis to determine the extent of demyelination and remyelination in Theiler's murine encephalomyelitis virus (TMEV)infected SJL/J mice
✦ LIBER ✦
Treatment of early-onset multiple sclerosis with intramuscular interferonβ-1a: long-term results
✍ Scribed by A. Ghezzi; M. P. Amato; M. Capobianco; P. Gallo; M. G. Marrosu; V. Martinelli; C. Milanese; L. Moiola; N. Milani; L. La Mantia; F. Patti; C. Pozzilli; M. Trojano; G. Comi; M. Zaffaroni; the Immunomodulatory Treatment of Early-onset MS (ITEMS) Group
- Publisher
- Springer Milan
- Year
- 2007
- Tongue
- English
- Weight
- 119 KB
- Volume
- 28
- Category
- Article
- ISSN
- 1590-1874
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Short-term treatment with interferon-α/β
✍
M. Kariuki Njenga; Michael J. Coenen; Nannette DeCuir; Hung-Yueh Yeh; Moses Rodr
📂
Article
📅
2000
🏛
John Wiley and Sons
🌐
English
⚖ 346 KB
👁 1 views
Long-term results of immunomodulatory tr
✍
Angelo Ghezzi; Maria Pia Amato; Pietro Annovazzi; Marco Capobianco; Paolo Gallo;
📂
Article
📅
2009
🏛
Springer Milan
🌐
English
⚖ 297 KB
Interferon-β1bleads to a short-term incr
✍
Joerg Kraus; Roland Bauer; Nikolaos Chatzimanolis; Britta Engelhardt; Jasmin Tof
📂
Article
📅
2004
🏛
Springer
🌐
English
⚖ 321 KB
New onset of rheumatoid arthritis during
✍
Saifeddin Alsalameh; Bernhard Manger; Peter Kern; Joachim Kalden
📂
Article
📅
1998
🏛
John Wiley and Sons
🌐
English
⚖ 128 KB
👁 1 views
Incidence of exacerbations in the first
✍
Dr. Omar A. Khan; J. Richard Hebel
📂
Article
📅
1998
🏛
John Wiley and Sons
🌐
English
⚖ 230 KB
👁 1 views
Lymphoblastoid interferon alfa-n1 improv
✍
Geoffrey C. Farrell; Bruce R. Bacon; Robert D. Goldin
📂
Article
📅
1998
🏛
John Wiley and Sons
🌐
English
⚖ 122 KB
👁 2 views
The aim of this study was to compare the short-term and long-term efficacy and safety of lymphoblastoid interferon with a recombinant interferon alfa (IFN-␣) in a 24-week treatment course for chronic hepatitis C. One thousand seventy-one patients with chronic hepatitis C were randomized to receive l